Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...

On average when positive, Signatera tests have a 98%-99% rate of accurately predicting the presence of cancer depending on the cancer, and the false-positive rate is less than 2% to 1% depending on ...

KYOTO—Kyoto University Hospital officials announced on April 14 that a research team conducted a clinical trial in February to transplant lab-grown pancreatic islets into a woman in her 40s who has ...